TI

Trends in cancer

Trends in Cancer is a member of the Trends review journals that publishes concise expert commentary on frontline research topics and advances in cancer discovery and medicine. It serves scientists, clinicians, policy makers, patients, and advocates with multidisciplinary discussion and education spanning basic, translational, and clinical findings, industry R&D, technology and innovation, ethics, and cancer policy and funding. Topics include adult and pediatric cancers, personalized medicine, tumor microenvironment, resistance and metastasis, immunotherapy, metabolism, genetics and epigenetics, diagnostics, biomarkers and treatment, epidemiology, and cancer prevention.

Looking to publish in Trends in cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 17.5
Quartile Q1
Open Access Type Hybrid
ISSN 2405-8033
eISSN 2405-8025
Invitation Only No
Cost Range Article Publishing Charges may be fully covered or discounted through institutional or consortial open access agreements.

Submission Instructions

Trends in cancer accepts the following article types. Click on an article type to view submission instructions.

Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must be 100 to 120 words. Abstract must be 100 to 120 words.
Manuscript Main text must be 3000 to 3500 words, excluding boxes, tables, figure legends, abstract, and references. Manuscript must use a short descriptive heading instead of “Introduction” for the introductory section, keep that section to one or two paragraphs, and end with “Concluding Remarks” or “Concluding Remarks and Future Perspectives.” Manuscript must include 3 to 5 Highlights in a separate Word file, a required Outstanding Questions Box in a separate Word file, at least two and no more than six keywords, and declaration of interests and generative AI statements in the text.
References Main text may include no more than 80 references. References must be numbered in square brackets in order of citation and listed in that same order rather than alphabetically.
Figures & Tables Reviews may contain up to six additional elements consisting of figures, tables, and text boxes, with no more than four text boxes permitted. Figures must be supplied as separate files, while tables must be created in Word and submitted as part of the main document rather than as separate files. Each figure legend must have a short explanatory title, fully explain the figure without referring to the text, and be no more than 250 words, while tables must have a single-sentence title and no legend.
Reformat to Trends in cancer using Livewrite Premium

Letters

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Main text must be 700 to 800 words, excluding references and any text in a box, table, or figure legend. Include affiliation details for all authors, indicate the corresponding author as “Correspondence: email address (initials and surname),” and provide at least two and no more than six keywords. Include a declaration of interests section in the text, and if generative AI was used in writing, add a section titled “Declaration of Generative AI and AI-assisted technologies in the writing process” immediately above the references specifying the tool used and the reason for using it.
References Letters may include no more than 12 references. References must be numbered in square brackets in order of citation and listed in that same order rather than alphabetically.
Figures & Tables Letters may contain one additional element consisting of one figure, one table, or one text box, and each text box must be no more than 200 words. Figures must be supplied as separate files rather than embedded in the main text document, whereas tables must be submitted as part of the main document rather than as separate files. Figure legends must have a short explanatory title and fully explain the figure without reference to the text, while tables must have a single-sentence title, no legend, footnoted abbreviations using superscript lowercase letters, and must not be inserted as images.
Reformat to Trends in cancer using Livewrite Premium

Recent Publications

Condensates in fusion oncoprotein-driven leukemia: new biology and therapeutic opportunities

Nicole L. Michmerhuizen, Richard W. Kriwacki, Charles G. Mullighan

10.1016/j.trecan.2026.04.009
View Publication

Defying inflammation-driven early-onset colorectal cancer: predict, prevent, and personalize

Taniya Murikkinthara Samuel, Samson Mathews Samuel, Elizabeth Varghese, Bini Sreenesh, Dietrich Büsselberg

10.1016/j.trecan.2026.05.005
View Publication

Mitochondrial transfer reveals an organellar layer of cancer ecology

Derick Okwan-Duodu, Bo Li, Edgar Engleman

10.1016/j.trecan.2026.05.006
View Publication

Subscription & copyright page

-

10.1016/s2405-8033(26)00122-6
View Publication

Advisory Board and Contents

-

10.1016/s2405-8033(26)00119-6
View Publication

Frequently asked questions

How long does it take to publish?

2 days from submission to first decision; 54 days from submission to acceptance.

Reformat to Trends in cancer using Livewrite Premium

What are the publication costs?

Institutional online access is available through subscription. The journal is described as available under subscription and open access models.

Reformat to Trends in cancer using Livewrite Premium

Research Topics

Diverse Scientific and Economic Studies Cancer Genomics and Diagnostics Cancer Immunotherapy and Biomarkers Legal Cases and Commentary Cancer Cells and Metastasis Epigenetics and DNA Methylation CAR-T cell therapy research Immunotherapy and Immune Responses Cancer, Hypoxia, and Metabolism Immune Cell Function and Interaction Immune cells in cancer Legal case studies and regulations Human auditory perception and evaluation RNA modifications and cancer Pancreatic and Hepatic Oncology Research Pharmacy and Medical Practices Single-cell and spatial transcriptomics DNA Repair Mechanisms Glioma Diagnosis and Treatment Cancer-related Molecular Pathways CRISPR and Genetic Engineering Genetic factors in colorectal cancer MicroRNA in disease regulation Protein Degradation and Inhibitors Lung Cancer Treatments and Mutations

Related Journals

PH
Public Health Elsevier BV
P&
Pharmacology & Therapeutics Elsevier BV
CN
Clinical Neurophysiology Elsevier BV
JO
Journal of Cystic Fibrosis Elsevier BV
TJ
The Journal of Pediatrics Elsevier BV
TJ
The Journal of Nutritional Biochemistry Elsevier BV